SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-19-000553
Filing Date
2019-07-24
Accepted
2019-07-24 16:55:02
Documents
61
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q inva-20190630x10q.htm   iXBRL 10-Q 1582819
2 EXHIBIT 31.1 inva-20190630ex311d9448b.htm EX-31.1 12787
3 EXHIBIT 31.2 inva-20190630ex3128a34e1.htm EX-31.2 12659
4 EXHIBIT 32 inva-20190630xex32.htm EX-32 15672
  Complete submission text file 0001410578-19-000553.txt   6854625

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA inva-20190630.xsd EX-101.SCH 47206
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE inva-20190630_cal.xml EX-101.CAL 68154
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE inva-20190630_def.xml EX-101.DEF 353016
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE inva-20190630_lab.xml EX-101.LAB 497028
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE inva-20190630_pre.xml EX-101.PRE 436160
10 EXTRACTED XBRL INSTANCE DOCUMENT inva-20190630x10q_htm.xml XML 1264174
Mailing Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005
Business Address 2000 SIERRA POINT PARKWAY SUITE 500 BRISBANE CA 94005 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 19971587
SIC: 2834 Pharmaceutical Preparations